BOGLE INVESTMENT MANAGEMENT L P /DE/ - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 43 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$505,000
-88.1%
108,963
-84.3%
0.04%
-88.0%
Q3 2015$4,228,000
-47.3%
694,382
-25.4%
0.30%
-49.8%
Q2 2015$8,027,000
+152.1%
931,257
+30.7%
0.60%
+173.1%
Q1 2015$3,184,000712,5110.22%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Abingworth LLP 861,723$1,174,0000.98%
R&F Capital Advisors LP 171,205$111,0000.04%
Rhenman & Partners Asset Management AB 200,000$130,0000.02%
Rock Springs Capital Management LP 380,000$247,0000.02%
WHITE PINE CAPITAL LLC 35,000$23,0000.01%
BVF INC/IL 62,292$40,0000.01%
Virtu KCG Holdings LLC 271,239$176,0000.00%
TURNER INVESTMENTS LLC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 11,736$8,0000.00%
Tower Research Capital LLC (TRC) 36,413$24,0000.00%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders